Literature DB >> 8144890

Binding of C3b and C4b by the CR1-like site in murine CR1.

K R Kalli1, D T Fearon.   

Abstract

We determined whether the six short consensus repeats (SCRs) that are appended to the amino terminus of murine CR2 to form murine CR1 contain a binding site for C4b in addition to that for C3b, and whether these sites overlap or are distinct. Human K562 transfectant cell lines were established that stably expressed constructs encoding variable combinations of these six murine SCRs attached to the amino terminus of a truncated form of human CR2 lacking its iC3b/C3dg binding site. These cell lines, and two others expressing full-length human CR1 and SCRs lacking its iC3b/C3dg binding site. These cell lines, and two others expressing full-length human CR1 and SCRs 8-11 of the C3b binding site of human CR1, respectively, were assessed for their capacity to form rosettes with sheep E bearing rat C4b or guinea pig C3b. K562 cells with full length human CR1 formed rosettes with both EC3b and EC4b, and the cells expressing the construct with human CR1 SCRs 8-11 bound only EC3b. The murine CR1/human CR2 chimera containing murine SCRs 1-6 resembled the full length human CR1 in binding both EC3b and EC4b. Deletion of SCRs 5-6 from the murine CR1/human CR2 chimera diminished in parallel, but did not abolish, binding of EC3b and EC4b. Constructs containing SCRs 2-5, SCRs 3-6, or SCRs 2-6 lacked activity, indicating an absolute requirement for SCR-1 for binding of both C3b and C4b. Therefore, murine CR1 binds both C3b and C4b, and the sites for these ligands have similar, if not identical, amino- and carboxyl-terminal boundaries.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144890

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Complement-dependent transport of antigen into B cell follicles.

Authors:  Santiago F Gonzalez; Veronika Lukacs-Kornek; Michael P Kuligowski; Lisa A Pitcher; Søren E Degn; Shannon J Turley; Michael C Carroll
Journal:  J Immunol       Date:  2010-09-01       Impact factor: 5.422

2.  Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner.

Authors:  M Paula Longhi; Baalasubramanian Sivasankar; Nader Omidvar; B Paul Morgan; Awen Gallimore
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

3.  Humoral response to herpes simplex virus is complement-dependent.

Authors:  X J Da Costa; M A Brockman; E Alicot; M Ma; M B Fischer; X Zhou; D M Knipe; M C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Amino acid patterns within short consensus repeats define conserved duplicons shared by genes of the RCA complex.

Authors:  Craig A McLure; Roger L Dawkins; Joseph F Williamson; Richard A Davies; Jemma Berry; Longman-Jacobsen Natalie; Rebecca Laird; Silvana Gaudieri
Journal:  J Mol Evol       Date:  2004-08       Impact factor: 2.395

5.  Molecular characterization of rat Crry: widespread distribution of two alternative forms of Crry mRNA.

Authors:  R J Quigg; C F Lo; J J Alexander; A E Sneed; G Moxley
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  Uncoupling CD21 and CD19 of the B-cell coreceptor.

Authors:  Robert A Barrington; Thomas J Schneider; Lisa A Pitcher; Thorsten R Mempel; Minghe Ma; Natasha S Barteneva; Michael C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-12       Impact factor: 11.205

7.  Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.

Authors:  Tao Lin; Wuding Zhou; Conrad A Farrar; Roseanna E G Hargreaves; Neil S Sheerin; Steven H Sacks
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

8.  Antibody response to a T-dependent antigen requires B cell expression of complement receptors.

Authors:  D A Croix; J M Ahearn; A M Rosengard; S Han; G Kelsoe; M Ma; M C Carroll
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

9.  Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.

Authors:  Y U Kim; T Kinoshita; H Molina; D Hourcade; T Seya; L M Wagner; V M Holers
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.